Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

8 823 evidences · page 22 / 353

3 %The sensitivity of microscopy and qPCR for detecting Plasmodium malariae infection was 3% and 10% respectively across communities.

Nigeriapaludismepublié 2019Seroprevalence and parasite rates of <i>Plasmodium malariae</i> in a high malaria transmeurope_pmcdocument de 6 observationsDOI 10.1101/725796

19 %Among adults aged 25–49 years, 19% had tested for HIV in the last 12 months preceding the 2016/2017 Multiple Indicator Cluster Survey in Nigeria.

NigeriaVIH/sidaobservé 2016/2017publié 2020AIDS carePubMeddocument de 5 observations

69,7 %69.7% of the women cited lack of knowledge of where to go for cervical cancer screening as a reason for not being screened.

Nigeriacancer du col de l'utéruspublié 2021The Pan African medical journalPubMeddocument de 8 observations

Lactate dehydrogenase (LDH) levels differed significantly among young Nigerian SCA patients when differentiated by UGT1A1 (TA)n genotypes (p < 0.05).

Nigeriadrépanocytosepublié 2019BMC medical geneticsPubMeddocument de 6 observations

34,5 %The prevalence of abnormal ECG findings in HIV-positive children was 34.5%.

NigeriaVIH/sidapublié 2020The Nigerian postgraduate medical journalPubMeddocument de 9 observations

The eGFR, spot urine albumin, and urine ACR were significantly higher in the HbS group compared to the HbA group.

Nigeriadrépanocytosepublié 2021Medical principles and practice : international journal of the Kuwait University, Health SPubMeddocument de 3 observations

1 200 000 deathsThere were an estimated 1.2 million TB deaths among HIV-negative people in 2019.

Nigeriatuberculoseobservé 2019publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 18 observations

2 965 125 ITNsThe 2021 ITN distribution campaign in Ondo state, Nigeria distributed 2,965,125 ITNs covering 1,057,577 households.

Nigeriapaludismeobservé 2021publié 2024Malaria journalPubMeddocument de 2 observations

22,3 %22.3% of participants were partially vaccinated against COVID-19.

NigeriaCOVID-19observé April-June 2024publié 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 8 observations

69 patientsStaphylococcus aureus was isolated from 69 (59.0%) of the 117 bacteremic patients in Ibadan, Nigeria.

Nigeriabacteraemiaobservé 16 June to 16 October 2017publié 2019Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 9 observations

8,2 %The prevalence of diabetes was 8.2% among persons without HIV in Nigeria.

Nigeriadiabète (non précisé)publié 2023BMC endocrine disordersPubMeddocument de 20 observations

103 per_1000From 2010 to 2019, national malaria incidence among children aged 0–4 years in Nigeria declined from 103 to 74.5 cases per 1000, representing a 27.7% reduction.

Nigeriapaludismeobservé 2010publié 2026Malaria journalPubMeddocument de 10 observations

1 180 suspected_casesNigeria reported 1,180 suspected mpox cases in 2024, with 78 confirmed cases across 24 states and the Federal Capital Territory.

Nigeriampoxobservé 2024Africa CDCdocument de 147 observations

1,89 odds_ratioThe adjusted odds ratio for low green vegetable consumption as a risk factor for ischemic stroke was 1.89 (95% CI: 1.45–2.46).

NigeriaAVCpublié 2022StrokePubMeddocument de 16 observations

100 μg/mLL'extrait éthanolique de graines de Peganum harmala inhibe Plasmodium falciparum à 99,8 % pour une concentration de 100 μg/mL.

NigeriapaludismeHAL · Unilimdocument de 173 observations

4,8 %HIV seronegative women uninfected with HSV-2 had a cervical lesion prevalence of 4.8%.

NigeriaCervical Lesions · Herpes Simplex Virus Type-2 · VIH/sidapublié 2022Current HIV researchPubMeddocument de 4 observations

10,4 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Nigeria était de 10,4 % en 2009.

NigeriaVIH/sidaobservé 2009HAL · Unilimdocument de 747 observations

11,4 %At first viral load for 402,668 patients during 2016–21, virological non-suppression occurred in 46,051 (11.4%) individuals.

NigeriaVIH/sidaobservé 2016–21publié 2022The Lancet. Global healthPubMeddocument de 5 observations

The mean gametocyte sex ratio was female-biased pre-treatment in both pyrimethamine-sulfadoxine-resistant and pyrimethamine-sulfadoxine-sensitive Plasmodium falciparum infections.

Nigeriapaludismepublié 2003Annals of tropical medicine and parasitologyeurope_pmcdocument de 5 observations

24,9 %Of the 8,329 eligible women in the 2018 Nigerian National Nutrition and Health Survey, 1,493 (24.9%) missed HIV pre-test counselling.

NigeriaVIH/sidaobservé 2018publié 2022African journal of reproductive healthPubMeddocument de 5 observations

0,72 odds_ratioDietary adherence was significantly associated with improved glycemic outcomes (OR 0.72; 95% CI 0.61–0.85).

Nigeriadiabète de type 2publié 2025Global health research and policyPubMeddocument de 5 observations

36 casesThirty-six (56.2%) of the 64 children with muco-cutaneous infection were unaware of their skin infection prior to consultation.

Nigeriaskin infectionpublié 2022West African journal of medicinePubMeddocument de 8 observations

Mefloquine alone and mefloquine/sulfadoxine/pyrimethamine both reduced parasitaemia and fever more rapidly than chloroquine in children with acute uncomplicated falciparum malaria.

Nigeriapaludismepublié 1995Transactions of the Royal Society of Tropical Medicine and HygieneOpenAlexdocument de 5 observations

2 %The prevalence of sickle cell disease was 2.0% among senior secondary school students in Surulere Local Government Area, Lagos, Nigeria.

Nigeriadrépanocytosepublié 2022African journal of primary health care & family medicinePubMeddocument de 11 observations

8,48 daysThe mean duration of hospitalization for HIV/AIDS admissions was 8.48 ± 7.08 days.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 11 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.